- MoTrPAC examined the molecular effects of exercise on 2,600 volunteers, incorporating factors like age, race, and gender diversity.
- Building upon research in rats, MoTrPAC discovered over 35,000 biological molecules responding to endurance exercise and widespread gender differences in responses.
- Initial findings from MoTrPAC underscore the importance of including both sexes in exercise research to fully understand its health implications, advocating for diverse representation in future studies.
- By tracking exercise's impact on biological molecules, MoTrPAC aims to develop personalized exercise regimens, offering tailored approaches to treat or prevent various health conditions.
Scientists Decode Exercise's Molecular Impact
For the past eight years, researchers have been conducting a groundbreaking study supported by the National Institutes of Health (NIH) Common Fund: The Molecular Transducers of Physical Activity Consortium (MoTrPAC). With nearly 2,600 volunteers, the study aims to examine the molecular effects of exercise on healthy adults and children, considering factors like age, race, and gender. The goal is to create comprehensive molecular maps of these changes and uncover why physical activity has significant health benefits.
"This is an unprecedented large-scale effort to begin to explore—in extreme detail—the biochemical, physiological, and clinical impact of exercise," said Russell Tracy, PhD., a University of Vermont Distinguished Professor of Pathology and Laboratory Science. "I'm pleased and honored that our lab at UVM was chosen to be the MoTrPAC Biorepository, and anticipate that the MoTrPAC 'maps,' when coupled with the carefully collected biosamples, will prove enormously useful over the next decade or more of related studies."
Preliminary Research Findings
In a series of papers published today (May 1) in Nature, MoTrPAC researchers laid out their preliminary findings. Scientists discovered unique molecular responses to endurance exercise in different tissues, with mitochondria exhibiting varied changes across the body. Notably, adrenal glands showed significant alterations in nearly half of mitochondria-associated genes following endurance training, a previously unexplored aspect.
Gender differences were observed in molecular responses across various tissues, particularly in white fat tissue, suggesting implications for personalized exercise recommendations, especially in conditions like obesity.
These findings underscore the importance of including both sexes in exercise research to comprehensively understand its health effects.
Research Technician Sandra May checks new samples into the UVM Laboratory for Clinical Biochemistry Research, a key site for the pioneering eight-year MoTrPAC study. Credit: University of Vermont
Funding and Methodology
Twenty-two grants—totaling approximately $226 million in Common Fund support—have bolstered the work of researchers across the country—including Tracy and Jessica Rooney, M.P.H., and other members of the Larner College of Medicine team at the University of Vermont. The study involves various exercise regimens and collects biospecimens before, during, and after exercise.
Recipients of the grant worked as a consortium to develop plans for recruitment into the clinical trial portion of MoTrPAC, identification of methods to analyze tissue samples, and selection of animal models to best replicate human studies. Animal models allowed researchers to search for changes in tissues not easily accessible in human patients, such as the brain, lungs, and kidneys.
Lessons learned from initial phases in animals were then used to optimize protocols for full-scale recruitment. The ultimate aim is to personalize exercise recommendations based on individual needs and traits, potentially leading to significant advancements in health and treatment approaches.
Consortium Network and Management
The MoTrPAC network is a robust one—The Consortium Coordinating Center (CCC), comprising the Administrative Coordinating Core (ACC), Biospecimens Repository Core (BRC), Exercise Intervention Core (EIC), and Data Management, Analysis, and Quality Control (DMAQC) Core, provide essential support to the dozens of teams involved in this project. Led by four principal investigators, the CCC collaborates with Clinical Sites, Preclinical Animal Study Sites, Bioinformatics Center, Chemical Analysis Sites, and various committees.
The CCC employs strategies for integration, safety monitoring, and effective communication. Wake Forest University School of Medicine serves as the hub, with the DMAQC Core managing many of the project's aspects. The CCC emphasizes rigorous research practices, real-time tracking, and extensive experience in coordinating large clinical trials. Its goals include fostering team science, ensuring research transparency, managing biological samples, coordinating preclinical studies, resource sharing, publishing results, and implementing analytical best practices.
Leadership and Future Prospects
Tracy is a key figure in MoTrPAC as one of the 4 principal investigators of the CCC, which secured $10 million in support. His specific role involves vice-chairing the MoTrPAC Steering Committee (SC) and leading the Biospecimens Repository Core (BRC). This core is responsible for collecting, storing, and managing biological samples from participants and animals involved in the study all of which must be done under cryopreservation conditions.
The biospecimens, which include blood, fat, and muscle tissues in humans, are crucial for the molecular analyses that aim to understand the changes occurring in the body due to exercise. His group then distributed these biological specimens to the MoTrPAC investigators, as well as other investigators who wish to conduct studies related to this large-scale exploration of the effects of exercise. Tracy's leadership in the BRC indicates his crucial role in designing and implementing the protocols for biospecimen collection and ensuring the quality and integrity of these samples throughout the study.
With additional findings from the MoTrPAC study being released throughout the coming year, Tracy and his colleagues are poised to reshape our understanding of exercise's molecular basis and impact on human health.
Reference: "Temporal dynamics of the multi-omic response to endurance exercise training" 1 May 2024, Nature.
DOI: 10.1038/s41586-023-06877-w
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
















